Studies of the 5' Exonuclease and Endonuclease Activities of CPSF-73 in Histone Pre-mRNA Processing by Yang, X.-c. et al.
MOLECULAR AND CELLULAR BIOLOGY, Jan. 2009, p. 31–42 Vol. 29, No. 1
0270-7306/09/$08.000 doi:10.1128/MCB.00776-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
Studies of the 5 Exonuclease and Endonuclease Activities of CPSF-73
in Histone Pre-mRNA Processing†
Xiao-cui Yang, Kelly D. Sullivan, William F. Marzluff, and Zbigniew Dominski*
Department of Biochemistry and Biophysics and Program in Molecular Biology and Biotechnology, University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599
Received 14 May 2008/Returned for modification 9 July 2008/Accepted 15 October 2008
Processing of histone pre-mRNA requires a single 3 endonucleolytic cleavage guided by the U7 snRNP that
binds downstream of the cleavage site. Following cleavage, the downstream cleavage product (DCP) is rapidly
degraded in vitro by a nuclease that also depends on the U7 snRNP. Our previous studies demonstrated that
the endonucleolytic cleavage is catalyzed by the cleavage/polyadenylation factor CPSF-73. Here, by using RNA
substrates with different nucleotide modifications, we characterize the activity that degrades the DCP. We show
that the degradation is blocked by a 2-O-methyl nucleotide and occurs in the 5-to-3 direction. The U7-
dependent 5 exonuclease activity is processive and continues degrading the DCP substrate even after complete
removal of the U7-binding site. Thus, U7 snRNP is required only to initiate the degradation. UV cross-linking
studies demonstrate that the DCP and its 5-truncated version specifically interact with CPSF-73, strongly
suggesting that in vitro, the same protein is responsible for the endonucleolytic cleavage of histone pre-mRNA
and the subsequent degradation of the DCP. By using various RNA substrates, we define important space
requirements upstream and downstream of the cleavage site that dictate whether CPSF-73 functions as an
endonuclease or a 5 exonuclease. RNA interference experiments with HeLa cells indicate that degradation of
the DCP does not depend on the Xrn2 5 exonuclease, suggesting that CPSF-73 degrades the DCP both in vitro
and in vivo.
3-end processing is an essential step in converting eukary-
otic mRNA precursors (pre-mRNAs) to mature mRNAs.
Metazoan pre-mRNAs are processed at the 3 end by two
distinct mechanisms (40). The vast majority of mRNA precur-
sors are processed by cleavage coupled to polyadenylation.
This mechanism depends on the presence of two sequence
elements in the precursor: a highly conserved polyadenylation
signal (AAUAAA) and a less conserved, G/U-rich downstream
element (6). Cleavage occurs between the two sequence ele-
ments, usually about 20 nucleotides 3 to the AAUAAA signal.
The upstream cleavage product is subsequently polyadenyl-
ated. Cleavage/polyadenylation is executed by a large complex
composed of at least 12 proteins. The AAUAAA signal inter-
acts with a 5-subunit cleavage/polyadenylation specificity factor
(CPSF) (17), whereas the G/U-rich downstream element in-
teracts with a 3-subunit cleavage stimulation factor (CstF) (6).
Among other proteins, the cleavage/polyadenylation machin-
ery also includes poly(A) polymerase, which catalyzes the ad-
dition of the poly(A) tail (6), and symplekin, which plays a
yet-uncharacterized role in 3-end processing (36). Increasing
numbers of both genetic and biochemical studies indicate that
endonucleolytic cleavage that proceeds polyadenylation is car-
ried out by CPSF-73, the 73-kDa subunit of CPSF (23, 30).
CPSF-73 is a member of the metallo--lactamase family of
mostly hydrolytic enzymes that utilize zinc ions during catalysis
(1, 4). A small group of the metallo--lactamase proteins func-
tion in metabolism of DNA and RNA substrates as endonucle-
ases and/or 5-to-3 exonucleases (4, 9, 24).
A distinct 3-end processing mechanism operates on meta-
zoan replication-dependent histone pre-mRNAs (10). These
transcripts are cleaved between a highly conserved stem-loop
structure and a purine-rich histone downstream element
(HDE) directly producing the mature histone mRNAs that
end with the stem-loop followed by a 5-nucleotide single-
stranded tail. 3-end processing of histone pre-mRNAs criti-
cally depends on the HDE, which interacts with U7 snRNP.
The interaction is mediated by formation of a double-stranded
RNA between the HDE and the 5 end of U7 snRNA, an
approximately 60-nucleotide component of the U7 snRNP.
The U7 snRNP contains an unusual Sm complex, in which the
Sm proteins D1 and D2 are replaced by two related proteins:
Lsm10 and Lsm11 (27, 28). The stem-loop structure forms a
tight complex with the stem-loop binding protein. The stem-
loop binding protein also binds a 100-kDa zinc finger protein
(ZFP100), which in turn interacts with Lsm11. This bridging
interaction is believed to stabilize U7 snRNP on the HDE (10).
In common with cleavage/polyadenylation, 3-end processing
of histone pre-mRNAs also involves symplekin, although its
role remains to be elucidated (19).
UV cross-linking studies demonstrated that the cleavage site
in histone pre-mRNAs interacts in a U7-dependent manner
with CPSF-73, thus strongly suggesting that the same endonu-
clease functions in generation of both polyadenylated and non-
adenylated (histone) mRNAs (11). Following the in vitro
cleavage reaction, the downstream product containing the
HDE is rapidly degraded to mononucleotides by a nuclease
that also depends on the U7 snRNA, giving rise to mononucle-
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otides (11). Our preliminary data suggested that also this re-
action is catalyzed by CPSF-73 (11).
In this study, we show that degradation of the downstream
cleavage product (DCP) is a result of a processive 5-to-3
exonuclease activity and further support the involvement of
CPSF-73. We also show that the position of the HDE relative
to the 5 end of the transcript determines whether cleavage is
endonucleolytic or exonucleolytic and provide in vivo data
suggesting that degradation of the DCP formed after 3-end
processing of histone pre-mRNA does not require Xrn2.
MATERIALS AND METHODS
Preparation and labeling of RNA substrates. Most RNAs were synthesized in
Dharmacon (Lafayette, CO) and, depending on the quality of synthesis, were
used either directly or gel purified to isolate the full-length product. RNA
substrates containing a single internal label were constructed by ligating two
RNA fragments by using DNA ligase and a bridging oligonucleotide, essentially
as described previously (25). Prior to ligation, the downstream fragment was
labeled at the 5 end with 32P by using T4 polynucleotide kinase, as described
previously (11). All RNA substrates were named based on the number of nu-
cleotides present in front of the DCP, for example, DCP, DCP5, or DCP2.
The names of the substrates containing a single internal label additionally re-
flected the position of a modified nucleotide relative to the DCP sequence:
2-O-methyl (m), deoxy (d), or phosphorothioate (s). The DCP10 and
DCP15 substrates were constructed by ligating the 5 end of the DCP9/s
substrate to 19- and 24-nucleotide RNA fragments, respectively. The ligation
products were gel purified, quantified, and labeled at the 5 end with 32P by using
T4 polynucleotide kinase. The internally labeled 86-nucleotide H2a pre-mRNA
containing the stem-loop structure and the HDE was synthesized by T7 tran-
scription in the presence of [-32P]UTP, as described previously (13).
Preparation of nuclear extracts and RNA processing and degradation. Nu-
clear extracts were prepared from mouse myeloma cells, as described previously
(13). Unless otherwise indicated, all processing and degradation reactions were
carried out for 90 min in the presence of 20 mM EDTA, as described previously
(13). The efficiency of degradation was calculated by comparing the amount of
the released radioactive mononucleotide to the amount of the input substrate
used in the reaction. The U7 dependence of processing and degradation reac-
tions was determined by using 100 ng of an anti-M oligonucleotide that is
complementary to the first 17 nucleotides of the mammalian U7 snRNA (11). A
2-O-methyl anti-D oligonucleotide directed to the first 19 nucleotides of the
Drosophila U7 snRNA was used at the same concentration as a negative control
(11). In some reactions, the U7 dependence was also confirmed by using 500 ng
(a 1,000-fold excess relative to the labeled substrate) of an RNA containing the
wild-type sequence of the HDE (wtHDE RNA). A corresponding RNA contain-
ing a 4-nucleotide mutation replacing the AAGA sequence with UUCU within
the HDE (mutHDE) was used at the same concentration as a negative control.
Processing and degradation reactions were inhibited by NP-40 at a final concen-
tration of 0.05%.
Analysis of processing products. After 90 min of incubation, processing reac-
tion mixtures were treated for 1 h with proteinase K at 0.5 g/l, diluted 5 with
a 7 M urea dye, and analyzed in low-resolution 8% polyacrylamide-7 M urea gels
to asses the reaction efficiency. The same samples were additionally analyzed in
high-resolution gels allowing separation of fragments that differ by 1 nucleotide.
Mononucleotides containing a phosphate at the 5 end were identified by elec-
trophoresis in 12% gels based on comigration with mononucleotides generated
by S1 nuclease, which leaves a 5 phosphate, or products of KOH hydrolysis,
which migrate 0.5 nucleotides faster due to the presence of an additional phos-
phate at the 3 end. The lengths of larger products were determined with
high-resolution 8% gels by comparison with appropriate size markers containing
the same sequence (5-labeled RNAs used for ligation) or with products of
partial KOH hydrolysis. In other cases, the lengths of final processing products
were determined by comparison with the lengths of processing intermediates
generated due to random stalling of the U7-dependent exonuclease at each
nucleotide.
UV cross-linking and immunoprecipitation. UV cross-linking experiments
were carried out as previously described (11). Processing reaction mixtures were
prepared in a final volume of 20 l (equivalent to two regular reaction mixtures)
and additionally contained 10 g of Saccharomyces cerevisiae tRNA (Invitrogen)
to reduce the amount of nonspecifically cross-linked proteins. Each processing
reaction mixture was incubated for 10 min at 32°C to initiate the degradation
process, and a 15-l aliquot was exposed at room temperature to 1 J of UV while
the remaining portion of the reaction mixture was incubated for additional 80
min to asses the extent of degradation. Following UV irradiation, reaction
samples were treated for 5 h with RNase A and proteins resolved by electro-
phoresis in a sodium dodecyl sulfate (SDS)-polyacrylamide gel. Immunoprecipi-
tation with anti-CPSF-73 (a gift from D. Bentley) was carried out under dena-
turing conditions, as described previously (11).
RNAi. RNA interference (RNAi) was performed using a two-hit method.
Briefly, 7  106 HeLa cells were plated into 24-well plates and transfected with
3 l of 20 M stock small interfering RNAs (siRNAs) (Xrn2-1, Xrn2-2, or a
combination of both) 24 h later. A day after the first siRNA treatment, cells were
split 1:3 into six-well plates and after another 24 h were retransfected with 4 l
of siRNA. Seventy-two hours after the second transfection, samples were col-
lected by addition of either Trizol (Invitrogen) or NP-40 lysis buffer directly to
the wells. The siRNA target sequences in the human Xrn2 mRNA were GGG
AAGAAAUAUUGGCAA (Xrn2-1) and AAGAGUACAGAUGAUCAUG
(Xrn2-2).
Quantitative reverse transcription-PCR (qRT-PCR). Total cell RNA (2.5 g)
was treated with DNase (Promega), and reverse transcription reactions were
performed with Moloney murine leukemia virus-reverse transcriptase (Invitro-
gen) using random hexamers to prime the cDNA. cDNA from the reaction
was added directly to quantitative PCR reaction mixtures containing 2 Sybr
green PCR master mix (Applied Biosystems) and oligonucleotide primers.
PCR was performed using a 7900HT PCR system (Applied Biosystems), and
data were analyzed using SDS 3.2 software (Applied Biosystems). Relative
stability values were calculated using CT values generated using the equa-
tion (CTsiRNADownstream  CTsiRNA3End)  (CTControlDownstream 
CTControl3End), where CTsiRNADownstream and CTsiRNA3End represent
threshold cycle (CT) values for a given siRNA-treated sample amplified with
the indicated primer set and CTControlDownstream and CTControl3End repre-
sent CT values for control-treated samples amplified using the same indicated
primer set. The oligonucleotide primers used were as follows: Hist2H2AA 3
End F (GGAGCAGTACGGCCTGGAT), Hist2H2AA 3 End R (CGACG
AGGAACTGAACAAGCT), Hist2H2AA #1 Downstream F (GGGACCCA
CTCATCGAAGAG), Hist2H2AA #1 Downstream R (CGCGCCGTCTTC
CATCT), Hist2H2AA #2 Downstream F (CCAGGGCGCTTTGGAAA),
Hist2H2AA #2 Downstream R (GAGCTGGGTCTTGGCTTCAC),
GAPDH 3 End F (CCGCACCTTGTCATGTACCA), GAPDH 3 End R
(CCCTAGAATAAGACAGGACAAGTAACTG), GAPDH Downstream F
(TCGCTCCAGTCCTAGGCTATCT), and GAPDH Downstream R (GGCT
GCCCACAGAATAGCTT).
RESULTS
U7-dependent degradation of the DCP1 substrate contain-
ing a site-specific radioactive phosphate. To study 3-end pro-
cessing of histone pre-mRNAs in vitro, we use an 86-nucleo-
tide derivative of the mouse H2a-614 pre-mRNA that contains
all necessary processing elements, including the stem-loop and
the HDE (Fig. 1A). The H2a substrate labeled by random
incorporation with [32P]UTP is processed in a mouse nuclear
extract to an upstream cleavage product containing the stem-
loop and to 5 monophosphate nucleosides that result from the
degradation of the DCP (Fig. 1B, lane 2) (11). 3-end process-
ing of histone pre-mRNAs proceeds in the presence of 20 mM
EDTA, which inhibits virtually all nonspecific nucleases
present in the mouse nuclear extract. Blocking the 5 end of
the U7 snRNA by a complementary 2-O-methyl oligonucleo-
tide (anti-M) at 10 ng/l prevents binding of the U7 snRNP to
the RNA substrate and abolishes processing (Fig. 1B, lane 3).
A 2-O-methyl oligonucleotide with an unrelated sequence tar-
geted to the 5 end of the Drosophila U7 snRNA (anti-D),
routinely used at the same concentration to measure the extent
of nonspecific effects, does not affect processing (not shown). A
synthetic RNA substrate with a sequence corresponding to the
DCP or extended at the 5 end by 1 or more nucleotides is also
degraded in a U7-dependent manner in nuclear extracts from
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mammalian (11, 38) and Drosophila (12) cells. Thus, the deg-
radation of the DCP can be uncoupled from the endonucleo-
lytic cleavage of histone pre-mRNA.
In our previous studies, we used a DCP1 RNA labeled at
the 5 end with a radioactive phosphate (11). The U7-depen-
dent degradation of this substrate was monitored by the accu-
mulation of 32P-labeled mononucleotides. Since substrates la-
beled at the 5 end have a number of limitations, including the
inability to follow degradation further into the body of the
RNA, in the current studies we used a DCP1 RNA con-
taining a single internal radioactive phosphate. The 39-nu-
cleotide DCP1 RNA was constructed by ligating an 18-
nucleotide upstream fragment (U. Half) with a 5-labeled,
21-nucleotide downstream fragment (D. Half) (Fig. 1C).
The DCP1 RNA contained a hydroxyl group at the 5 end
and a single radioactive phosphate between residues 17 and 18
of the DCP, near the center of the HDE. Incubation of this
RNA in a mouse nuclear extract under standard conditions (20
mM EDTA) resulted in a release of the labeled mononucleo-
tide from the body of the RNA, with a small amount of the
product visible after 5 min of incubation (Fig. 1D, lanes 1 to 5).
The nuclease functions processively since only relatively small
amounts of intermediates were detected during the 60-min
reaction. The anti-M oligonucleotide at 10 ng/l blocked deg-
radation of the DCP1 substrate, whereas the anti-D oligo-
nucleotide at the same concentration had no effect (Fig. 1D,
lanes 6 to 8), demonstrating that nuclease activity depends
specifically on binding of the U7 snRNP to the HDE.
In order to release the radioactive nucleotide, the nuclease
had to remove nearly half of the HDE that is required to
recruit the U7 snRNP. We carried out a competition experi-
ment to determine whether RNAs containing only partial
HDE sequences can bind the U7 snRNP and therefore inhibit
processing of the H2a-614 pre-mRNA. We used the down-
stream and the upstream DCP halves (D. Half and U. Half,
respectively) (Fig. 1C), each at a 1,000-molar excess over the
pre-mRNA substrate. Neither the D. Half nor the U. Half
RNAs, containing 9 and 6 nucleotides of the HDE, respec-
tively, affected the processing of the pre-mRNA substrate (Fig.
1E, lanes 5 and 6). In contrast, the same molar excess of the
DCP1 RNA containing the entire HDE prevented cleavage
of the H2a-614 pre-mRNA (Fig. 1E, lane 4). Thus, the removal
of the first 6 nucleotides of the HDE during the degradation of
the DCP likely displaces the U7 snRNP from the RNA sub-
strate. We also tested whether 5-labeled D. Half and U. Half
RNAs can be degraded in a mouse nuclear extract in a U7-
dependent manner. Consistent with the inability of partial
HDE sequences to bind the U7 snRNP, neither substrate gen-
erated U7-dependent degradation products (not shown).
In the above-described experiment, the DCP1 substrate
was labeled internally with a single radioactive phosphate and
contained a hydroxyl group at the 5 end. The fact that this
substrate was efficiently degraded demonstrates that the U7-
dependent nuclease does not require a phosphate at the 5
end. To determine whether the addition of a 5 phosphate can
stimulate the degradation efficiency, we incubated the DCP1
RNA with T4 polynucleotide kinase and unlabeled ATP and
tested the resulting 5 phosphorylated substrate in a nuclear
extract. The efficiency of degradation was not significantly in-
creased (not shown), indicating that the U7-dependent nucle-
ase activity does not prefer substrates with a 5 phosphate.
U7-dependent degradation of RNA substrates containing
modified nucleotides upstream of the HDE. The DCP1 sub-
strate used in our previous studies, referred to here as DCP1/
s1, contained a phosphorothioate group between the first and
the second nucleotides (11). The presence of the modification
did not block the release of the 5-labeled mononucleotide but
FIG. 1. U7-dependent degradation of the DCP generated during
3-end processing of histone pre-mRNAs. (A) Fragment of the 86-
nucleotide mouse histone H2a pre-mRNA substrate encompassing
processing elements (top sequence) and the base pair interaction be-
tween the HDE (indicated with a thick line) and the U7 snRNA
(bottom sequence). The cleavage site and the DCP are indicated with
an arrowhead and a double-arrowed line, respectively. The Sm site in
the U7 snRNA is indicated with a box. (B) In vitro processing of the
internally labeled 86-nucleotide H2a substrate in a mouse nuclear
extract (NE) under control conditions (lane 2) or in the presence of an
oligonucleotide blocking the U7 snRNA (anti-M; lane 3). Lane 1
contains the unprocessed input pre-mRNA (Unproc). The 48-nucleo-
tide processing product (Proc) results from cleavage of the input after
the fifth nucleotide 3 of the stem-loop. (C) The sequence of the
DCP1 RNA containing a single radioactive phosphate between nu-
cleotides 17 and 18 of the DCP sequence (see Materials and Methods
for the terminology used to designate RNA substrates). The DCP1
RNA was constructed by ligating the upstream and the downstream
halves, with the downstream half containing the radioactive phosphate
at the 5 end (indicated with an asterisk). The HDE interacting with
the U7 snRNA is underlined. (D) Sixty-minute time course of the
U7-dependent degradation of the DCP1 RNA in a mouse nuclear
extract (lanes 1 to 5) and the effect of an oligonucleotide blocking
either the mouse U7 snRNA (anti-M; lane 7) or Drosophila U7
snRNA, used as a nonspecific control (anti-D; lane 8). (E) In vitro
processing of the 5-labeled H2a-614 pre-mRNA either under control
conditions (lane 2) or in the presence of a 1,000-fold molar excess of
RNA competitors containing either complete (lane 4) or partial (lanes
5 and 6) HDE. The processing shown in lane 3 was carried out in the
presence of the anti-M oligonucleotide.
VOL. 29, 2009 CPSF-73 NUCLEOLYTIC ACTIVITY IN NUCLEAR EXTRACTS 33
was absolutely required for cross-linking of the CPSF-73 to the
scissile bond by presumably slowing down the rate of catalysis.
To determine the effect of the phosphorothioate modification
on the activity of the U7-dependent nuclease in more detail,
we constructed a DCP1/s4 substrate containing a single phos-
phorothioate bond between nucleotides 4 and 5 of the DCP
sequence and a single radioactive phosphate between nucleo-
tides 17 and 18 (Fig. 2A) (see Materials and Methods for the
terminology used to name RNA substrates). Under control
reaction conditions, about 40% of the input RNA was con-
verted into equal amounts of two labeled products: an inter-
mediate migrating slightly faster than the input RNA and
mononucleotides (Fig. 2B, lane 2). High-resolution gel elec-
trophoresis demonstrated that the intermediate is 35 nucleo-
tides long, consistent with the removal of 4 nucleotides prior to
the encounter with the modified bond (Fig. 2B, lane 8). The
reaction was abolished by the presence of the anti-M oligonu-
cleotide or a 1,000-molar excess of an RNA containing the
wild-type HDE (wtHDE), each of which prevents the interac-
tion of the U7 snRNP with the substrate (Fig. 2B, lanes 3 and
5). Surprisingly, the degradation of the DCP1/s4 substrate
was significantly enhanced by the same molar excess of an
RNA bearing a 4-nucleotide substitution within the HDE
(mutHDE), although the same proportion of the two products
was observed (Fig. 2B, lane 6). This mutant competitor RNA
is unable to bind U7 snRNA and to undergo the U7-dependent
degradation (11). Our preliminary studies indicate that the
stimulatory effect is caused by sequestering an hnRNP protein,
which is present in high concentrations in many of our nuclear
extracts and may interfere with the recruitment of the U7
snRNP to the HDE (see below).
The degradation pattern of the DCP1/s4 substrate demon-
strated that the nuclease proceeds from the 5 end and stalls
with a frequency of about 50% at the modified nucleotide, thus
behaving as a typical 5 exonuclease. To further support the
5-3 polarity of the U7-dependent nuclease and to character-
ize its tolerance for other nucleotide modifications, we used
the DCP1/d5 substrate, containing a single deoxynucleotide
at position 5 of the DCP sequence and an internal radioactive
phosphate between nucleotides 17 and 18 (Fig. 2A). The deg-
radation of the DCP1/d5 RNA resulted in an efficient release
of the labeled mononucleotide, and only a small amount of a
34-nucleotide product was detected (Fig. 2C, lane 2), demon-
strating that deoxynucleotides are only a minor obstacle for the
5 exonuclease. The exonuclease activity was inhibited by
blocking the U7 snRNA with the anti-M oligonucleotide (Fig.
2C, lane 3) or a 1,000-molar excess of the wtHDE substrate
(Fig. 2C, lane 5). Moreover, the reaction was completely abol-
ished by 0.05% NP 40 (Fig. 2C, lane 6), previously shown to
inhibit the recruitment of CPSF-73 by the U7 snRNP during
endonucleolytic cleavage of histone pre-mRNA (11).
We also replaced the fifth and sixth nucleotides of the DCP
sequence in the DCP1 RNA with their 2-O-methyl analogs,
creating the DCP1/m5-6 substrate (Fig. 2A). 2-O-Methyl-
modified nucleotides significantly increase the resistance of
RNA substrates against a variety of nucleases (20). Incubation
of this substrate with a mouse nuclear extract did not yield any
mononucleotides and instead resulted in the accumulation of a
single product that was shorter by a few nucleotides than the
input RNA (Fig. 2D, lanes 1 to 5) but significantly longer than
the 21-nucleotide downstream-half RNA corresponding to the
last 21 nucleotides of the DCP1 RNA (Fig. 2D, lane 6). The
generation of this product was blocked by the anti-M oligonu-
cleotide (Fig. 2D, lane 8) and was not significantly stimulated
by the presence of a 5 phosphate on the DCP1/m5-6 sub-
strate (not shown). High-resolution gel electrophoresis re-
vealed that the accumulated product was 34 nucleotides long
(Fig. 2D, lanes 10 to 13). In addition to this major product,
there was also a small amount of a 1-nucleotide-shorter frag-
ment. Thus, the nuclease begins degradation from the 5 end
and stalls predominantly at the first modified nucleotide, with
the second modified nucleotide completely preventing further
FIG. 2. U7-dependent degradation of RNA substrates containing
modified nucleotides upstream of the HDE. (A) Sequence of the
DCP1/s4, DCP1/d5, and DCP1/m5-6 RNA substrates labeled in-
ternally with a single radioactive phosphate. The modified positions
are indicated with the appropriate letters (s, d, or m), and the radio-
active phosphate is indicated with an asterisk. (B) U7-dependent deg-
radation of the DCP1/s4 substrate (lanes 1 to 6) in a mouse nuclear
extract (NE) under control conditions (lane 2) or in the presence of
various RNA competitors, indicated at the top of each lane (lanes 3 to
6). The lengths of the RNA substrates and the positions of labeled
mononucleotides are indicated. The RNA products shown in lanes 5
and 6 were additionally resolved by high-resolution gel electrophoresis
(lanes 7 and 8; the radioactive mononucleotide is not shown). (C) U7-
dependent degradation of the DCP1/d5 RNA in a mouse nuclear
extract under control conditions (lane 2) or in the presence of various
RNA competitors or 0.05% NP-40, as indicated at the top of each lane
(lanes 3 to 6). (D) Sixty-minute time course of the U7-dependent
degradation of the DCP1/m5-6 RNA in a mouse nuclear extract
(lanes 1 to 5) and the effect of the anti-M (lane 8) or anti-D (lane 9)
oligonucleotides. The 21-nucleotide downstream-half RNA (D. Half)
labeled at the 5 end is shown in lane 6. High-resolution gel analysis of
the DCP1/m5-6 RNA and the degradation products generated under
control conditions or in the presence of the anti-M oligonucleotide are
shown in lanes 10 to 12.
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progression of the enzyme and protecting the downstream
labeled sequence. Overall, these experiments provide conclu-
sive evidence that the DCP generated during 3-end processing
of histone pre-mRNAs is degraded 5 to 3 by a U7-dependent
exonuclease.
Effects of modified residues located within the HDE on
U7-dependent degradation. The substrates described above
contained modified nucleotides upstream of the HDE. We
next incorporated the same modifications within the HDE and
tested their effects on the efficiencies of degradation of the
resulting substrates. A single 2-O-methyl nucleotide placed in
position 17 or 19 of the DCP sequence, i.e., immediately before
or after the radioactive phosphate (Fig. 3A), did not affect the
overall degradation efficiencies of the respective substrates,
DCP1/m17 and DCP1/m19, indicating that this modification
does not interfere with U7 snRNP binding (Fig. 3B, lanes 2
and 6). The degradation pattern of each substrate was consis-
tent with the predicted properties of the U7-dependent exo-
nuclease, which degrades in the 5-to-3 direction and stalls at
the modified nucleotide. The DCP1/m17 substrate was de-
graded to an intermediate that migrates slightly slower than
the 5-labeled, 21-nucleotide downstream half (Fig. 3B, lane 9)
and, as shown using high-resolution gel electrophoresis, is 22
nucleotides long (see Fig. S1, lane 8, in the supplemental
material). The DCP1/m19 substrate has the modified nucle-
otide 3 of the radioactive phosphate and yielded labeled 5
UMP when incubated in the nuclear extract (Fig. 3B, lane 6).
As shown for the DCP1/s4 substrate (Fig. 2), a 1,000-molar
excess of the mutHDE RNA significantly increased the effi-
ciencies of degradation of both the DCP1/m17 (see Fig. S1,
lane 3, in the supplemental material) and the DCP1/m19
RNAs (not shown).
Placing a phosphorothioate modification between nucleo-
tides 18 and 19 of the DCP sequence in DCP1/s18 (Fig. 3A)
greatly reduced the efficiency of degradation. Small amounts of
two labeled products were generated, a 21-nucleotide interme-
diate and 5 UMP, with an overall efficiency of about 5% (Fig.
3C, lane 2). This efficiency was only moderately enhanced by a
1,000-molar excess of the mutHDE, which removes a nonspe-
cific inhibitor (Fig. 3C, lane 5). Interestingly, the degradation
reaction predominantly yielded the 21-nucleotide product and
very few mononucleotides. Thus, a phosphorothioate modifi-
cation located within the HDE constitutes a much stronger
block for the U7-dependent 5 exonuclease than a phosphoro-
thioate located near the 5 end (see below). The poor degra-
dation of the DCP1/s18 substrate most likely results from the
lower thermal stability of the duplex formed between the mod-
ified HDE and the U7 snRNA and thus inefficient recruitment
of the 5 exonuclease to the substrate (7).
We also tested the effect of placing three consecutive de-
oxynucleotides in positions 13 to 15 in the DCP1/d13-15 RNA
(Fig. 3A). Degradation of this substrate under normal reaction
conditions was nearly completely inhibited (Fig. 3D, lane 2).
However, in contrast to that for the DCP1/s18 substrate, the
degradation efficiency for the DCP1/d13-15 substrate was
strongly stimulated by the presence of the mutHDE RNA,
reaching the level typical of other substrates (Fig. 3D, lane 6).
High-resolution gel electrophoresis revealed the presence of
three closely migrating intermediates, with lengths of 24, 25,
and 26 nucleotides (Fig. 3D, lane 10). This degradation pattern
is consistent with the fact that the U7-dependent nuclease
partially stalls at the single deoxynucleotide in the DCP1/d5
RNA (Fig. 2C) and indicates that three deoxynucleotides
within the HDE are sufficient to completely block further pro-
gression of the exonuclease, preventing the release of the ra-
dioactive mononucleotide. The fact that the DCP1/d13-15
RNA is degraded with the normal efficiency in the presence of
the mutHDE indicates that the incorporation of the three
deoxynucleotides does not abolish the ability of the HDE to
interact with the U7 snRNP and further supports a previous
conclusion that the only role of the HDE is to form a suffi-
ciently stable duplex with the U7 snRNA (2, 31). We predict
that the three deoxynucleotides within the HDE stimulate in-
FIG. 3. Effects of modified nucleotides located within the HDE on
the U7-dependent degradation. (A) Sequences of the DCP1/m17,
DCP1/m19, DCP1/s18, and DCP1/d13-15 substrates labeled inter-
nally with a single radioactive phosphate. The HDE is underlined, and
the position of the radioactive phosphate is indicated with an asterisk.
(B) U7-dependent degradation of the DCP1/m17 (lanes 2 to 4) and
DCP1/m19 (lanes 6 to 8) substrates in a mouse nuclear extract (NE)
under control conditions (lanes 2 and 6) or in the presence of oligo-
nucleotides blocking the mouse (anti-M; lanes 3 and 7) or Drosophila
(anti-D, lanes 4 and 8) U7 snRNA. Lane 9 contains the 5-labeled,
21-nucleotide downstream-half RNA. (C) U7-dependent degradation
of the DCP1/s18 RNA in a mouse nuclear extract in the absence
(lanes 2 to 4) or in the presence (lanes 5 to 7) of the mutHDE
competitor. Lane 8 contains the 5-labeled, 21-nucleotide downstream-
half RNA. (D) U7-dependent degradation of the DCP1/d13-15 RNA
in a mouse nuclear extract in the absence (lanes 2 to 4) or in the
presence (lanes 6 to 8) of the mutHDE competitor. The RNA samples
shown in lanes 5 and 6 were additionally analyzed by high-resolution
gel electrophoresis (lanes 9 and 10). Lanes 1 and 5 contain smaller
amounts of the substrate.
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teraction of the HDE with an inhibitory hnRNP protein and
hence cause a poor recruitment of the U7 snRNP in the ab-
sence of the mutHDE RNA.
Degradation of a substrate containing a radioactive phos-
phate downstream of the HDE. The above-described experi-
ments demonstrated that the U7-dependent 5 exonuclease
can remove at least the first 19 nucleotides of the DCP1
RNA, releasing labeled 5 UMP. To determine whether the
exonuclease can progress further into the body of the RNA
substrate to remove the entire U7 binding site, we used a
60-nucleotide substrate (3extDCP) created by ligating the
DCP1 RNA to a 5-labeled, 21-nucleotide RNA designated
3ext. In the 3extDCP substrate, the only radioactive phos-
phate was located 12 nucleotides downstream of the 3 end of
the HDE (Fig. 4A). Incubation of the 3extDCP substrate in a
mouse nuclear extract resulted in a U7-dependent accumula-
tion of labeled 5 AMP, indicating that the 5 exonuclease can
remove at least 40 nucleotides from the 5 end (Fig. 4B, lane
6), progressing completely through the HDE and displacing
the U7 snRNP. Compared to the degradation of the DCP1/m19
(Fig. 4B, lane 2) substrate, the degradation of the 3extDCP
substrate was less efficient. Since the two substrates have the
same sequence for the first 39 nucleotides, including the HDE,
the most likely explanation for the inefficient degradation of
the 3extDCP is an inhibitory effect of the additional 21 nucle-
otides located at the 3 end on the recruitment of the U7
snRNP (see below). As observed for other substrates, the deg-
radation efficiency of the 3extDCP substrate can be signifi-
cantly improved by the presence of a high excess of the
mutHDE RNA (Fig. 4B, lane 12).
Detecting U7-dependent interactions during degradation of
the DCP. To identify proteins that interact with the cleavage
site during DCP degradation, we carried out UV cross-linking
studies. The RNA substrates used in these studies contained a
number of minor changes compared to the DCP1 substrate
used in the above-described studies. First, we established that
reducing the number of nucleotides that follow the HDE from
12 to 4 has a stimulatory effect on the efficiency of degradation
(not shown). Moreover, instead of using DCP derivatives that
were extended at the 5 end by 1 nucleotide (DCP1 sub-
strates) we used RNA substrates that began immediately after
the cleavage site (DCP substrates). Finally, to have a choice of
using either RNase A or RNase T1 in cross-linking studies, we
replaced the first guanosine in the DCP with uridine (Fig. 5A).
This change was expected to be neutral for the U7-dependent
degradation since the region located between the HDE and the
cleavage site is not conserved (2). Indeed, we tested an RNA
substrate in which this sequence was completely changed
(DCPvar/s) and did not observe any changes in the efficiency of
degradation (Fig. 5A and B).
To slow down catalysis during degradation and thus allow
UV cross-linking of the 5 exonuclease to the DCP substrate, a
phosphorothioate modification (s) was placed in the first phos-
phodiester bond. This substrate, referred to as DCP/s (Fig.
5A), was degraded in a mouse nuclear extract with an efficiency
of about 40% (Fig. 5C, lane 2). To form UV cross-links, the
DCP/s RNA was incubated with a mouse nuclear extract for 10
min at 32°C, the time required to initiate degradation. The
reaction samples were subsequently UV irradiated, treated
with RNase A, and analyzed on SDS gels for the presence of
FIG. 4. Degradation of the 3extDCP RNA containing a single
radioactive phosphate downstream of the HDE. (A) Sequence of the
60-nucleotide 3extDCP RNA. The HDE is underlined, and the posi-
tion of the radioactive phosphate is indicated with an asterisk. The
3ext RNA is indicated with a double-arrowed line. (B) U7-dependent
degradation of the 3extDCP RNA under control conditions (lane 6
and 10) or in the presence of various RNA competitors, as indicated at
the top of each lane. The degradation efficiency for the DCP1/m19
RNA (Fig. 3A) is shown in lanes 1 to 4 for comparison. NE, nuclear
extract.
FIG. 5. Detecting U7-dependent interactions during degradation
of the DCP. (A) Sequence of the DCPvar/s and DCP/s substrates
containing a single radioactive phosphate at the 5 end (asterisk) and
a phosphorothioate modification (s) between nucleotides 1 and 2. (B
and C) U7-dependent degradation of the DCPvar/s (B) and DCP/s
(C) substrates under control conditions or in the presence of the
anti-M oligonucleotide, as indicated at the top of each line. NE, nu-
clear extract. (D) Formation of the U7-dependent cross-link between
CPSF-73 and the scissile bond in the DCP/s substrate. The substrates
were incubated with a mouse nuclear extract either under control
conditions (lane 2) or in the presence of the anti-M oligonucleotide
(lane 1). After brief incubation, the reaction mixtures were UV irra-
diated, treated with RNase A, and separated on an SDS-polyacryl-
amide gel. The identity of the CPSF-73 cross-link was confirmed by
immunoprecipitation with an anti-CPSF-73 antibody (lane 3).
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radioactively labeled proteins. RNase A cleaves the DCP/s
RNA immediately after the labeled cytosine (Fig. 5A), thus
allowing identification of proteins that interact only with the
first scissile bond. A single U7-dependent cross-link migrating
at 80 to 85 kDa was readily detected (Fig. 5D, lane 2) and its
identity determined by immunoprecipitation with anti-
CPSF-73 antibody to be CPSF-73 (Fig. 5D, lane 3). The fact
that CPSF-73 was the only protein cross-linked to DCP/s RNA
in a U7-dependent manner is consistent with the idea that
CPSF-73 functions as the 5 exonuclease.
Minimal space upstream of the HDE required for exonu-
cleolytic degradation. We asked whether the DCP9/s RNA,
containing only 2 nucleotides upstream of the HDE and a
phosphorothioate modification in the first phosphodiester
bond (Fig. 6A), could be efficiently degraded by the U7-de-
pendent 5 exonuclease. Significantly, a 90-min incubation of
the 5-labeled DCP9/s RNA in a nuclear extract did not yield
labeled mononucleotides (Fig. 6B, lane 2). The failure to un-
dergo degradation did not result from the proximity of the
phosphorothioate modification to the HDE and poor recruit-
ment of the U7 snRNP, since a molar excess of unlabeled
DCP9/s RNA competed a control degradation reaction with
the same efficiency as the full-length DCP (see Fig. S2B in the
supplemental material). In addition, extension of the 5-la-
beled DCP9/s RNA by a 14-nucleotide fragment converted
the DCP9/s RNA to a substrate that was efficiently degraded
(see Fig. S2C, lane 2, in the supplemental material). From this
analysis we conclude that the inability of the DCP9/s RNA to
undergo U7-dependent degradation is caused by an insufficient
space upstream of the HDE.
To determine the minimal size of the region located up-
stream of the HDE that is required to support the degradation
process, we tested a set of gradually shortened DCP substrates:
DCP2/s, DCP4/s, and DCP7/s (Fig. 6A). Only the
DCP2/s substrate was degraded in the extract by the U7-
dependent 5 exonuclease, whereas the other two substrates
were stable (Fig. 6C). The DCP2/s RNA was reproducibly
degraded with lower efficiency (25 to 30% of the input) than
the DCP/s RNA, further emphasizing the importance of an
optimal length upstream of the HDE. We conclude that sub-
strates containing only 7 nucleotides upstream of the HDE
(DCP4 or shorter) despite containing the entire HDE are
not degraded by the U7-dependent 5 exonuclease. An addi-
tional important conclusion from this analysis is that if the
U7-dependent 5 exonuclease dissociated from the RNA sub-
strate after removal of the first 4 nucleotides, it would be
unable to act again on the same RNA molecule. The lack of
intermediates of this length further supports our initial obser-
vation that the 5 exonuclease acts processively.
We tested whether CPSF-73 can also be UV cross-linked to
the modified scissile bond in the DCP2/s RNA. Compared to
all previously tested substrates, the modified bond in the
DCP2/s RNA is located within the body of the DCP and
relatively close to the HDE. Importantly, DCP2/s RNA also
formed a U7-dependent cross-link migrating at about 80 kDa
(Fig. 6D, bottom, lanes 1 and 3) that was identified by immu-
noprecipitation as CPSF-73 (not shown). The efficiency of
CPSF-73 cross-linking was relatively low due to the suboptimal
character of the DCP2/s RNA, which contains the shortest
region upstream of the HDE supporting degradation. We ad-
ditionally used DCP2max/s RNA, a derivative of DCP2/s
RNA containing the improved HDE that allows for an unin-
terrupted 15-bp duplex with the U7 snRNA (Fig. 6 A). As
expected, CPSF-73 cross-linked to the DCP2max/s RNA
more efficiently than to the DCP2/s RNA, reflecting the
more stable association of the U7 snRNP (Fig. 6E, bottom,
lanes 1 and 3).
Switching between the 5 exonuclease and endonuclease
modes. In our previous study, we used a DCP substrate that
was extended at the 5 end by 5 nucleotides and contained a
phosphorothioate modification at the cleavage site (11). This
substrate, previously called HDE5/s and renamed here to
FIG. 6. Minimal space upstream of the HDE required for exonu-
cleolytic degradation. (A) Sequence of the DCP derivatives truncated
upstream of the HDE. All substrates were labeled at the 5 end and
contained a phosphorothioate modification (s) between nucleotides 1
and 2. (B) U7-dependent degradation of the DCP9/s substrate under
control conditions or in the presence of the anti-U7 oligonucleotides,
as indicated. NE, nuclear extract. (C) U7-dependent degradation of
the DCP2/s, DCP4/s, and DCP7/s substrates under control con-
ditions or in the presence of the anti-M oligonucleotide, as indicated.
(D) The DCP2/s and DCPmax/s substrates were analyzed for U7-
dependent degradation (top) and UV cross-linking to CPSF-73 (bot-
tom). The reactions were carried out under control conditions or in the
presence of the anti-U7 oligonucleotides or NP-40, as indicated. UV
cross-linking was performed as explained in the legend to Fig. 5. The
position of the CPSF-73 cross-link is indicated with an arrow. (E) The
DCP2max/s substrate was analyzed for U7-dependent degradation
(top) and UV cross-linking to CPSF-73 (bottom). The reactions were
carried out under control conditions or in the presence of the anti-M
oligonucleotide, as indicated.
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DCP5/scs (Fig. 7A), when labeled at the 5 end and incubated
in a mouse nuclear extract yielded labeled mononucleotides
diagnostic of the 5 exonuclease mode (11). There was no
detectable 5-nucleotide fragment produced, demonstrating
that this substrate is not cleaved endonucleolytically (11). In
the nuclear extract used in these studies, incubation of the
DCP5/scs substrate again predominantly yielded labeled
mononucleotides (Fig. 7B, lane 1). One explanation for the
predominant 5 exonucleolytic degradation was that the pres-
ence of phosphorothioate at the cleavage site makes endonu-
cleolytic attack by CPSF-73 less favorable than cleavage at the
most proximal bond lacking any modification. To test this
possibility, we designed a new substrate, DCP5/s5, contain-
ing a phosphorothioate modification at the first phosphodi-
ester bond rather than within the cleavage site (Fig. 7A). This
substrate was nearly exclusively cleaved after the first nucleo-
tide, releasing labeled mononucleotides (not shown). These
results indicate that CPSF-73 preferentially utilizes the 5 exo-
nucleolytic mode of its activity if a substrate contains only 5
nucleotides upstream of the cleavage site. To determine
whether the predominant cleavage after the first nucleotide
results from the inherent inability of the DCP5 substrate to
undergo endonucleolytic cleavage, we next analyzed the pat-
tern of degradation of DCP5/m5 RNA, in which the first
nucleotide was modified by a 2-O-methyl group (Fig. 7A).
This modification renders phosphodiester bonds fully resistant
to hydrolysis by CPSF-73 and hence was expected to block the
5 exonuclease activity. The U7-dependent products generated
by incubation of this substrate in a nuclear extract were re-
solved by high-resolution gel electrophoresis next to products
of complete digestion of the same RNA by yeast 5 exoribo-
nuclease Xrn1 and endonuclease S1 (Fig. 7B, lanes 3 and 4).
These two nucleases generate a phosphate at the 5 end, and
thus, their products serve as appropriate size markers for the
CPSF-73-generated products. To unambiguously determine
the sizes of the degradation products, we also used a mixture of
two chemically synthesized fragments: mACC and mACCC
(Fig. 7B, lane 6). As expected, degradation of the DCP5/m5
RNA in the nuclear extract did not release labeled mononucle-
otides and instead generated a group of major U7-dependent
products consisting of 2, 3, and 4 nucleotides (Fig. 7B, lane 2).
There was also a small amount of a 5-nucleotide product that
resulted from hydrolysis at the natural endonucleolytic cleav-
age site. Interestingly, as judged by the accumulation of labeled
mononucleotides, the first phosphodiester bond in the
DCP5/m5 RNA was readily hydrolyzed by Xrn1 (Fig. 7B,
lane 3). This could be a biologically relevant feature of Xrn1 5
exonuclease, as many mRNAs that are degraded by Xrn1 in
vivo contain 2-O-methyl-modified nucleotides near the 5 end
as a part of the cap structure. We conclude that CPSF-73
strongly prefers to cleave after the first nucleotide of the
DCP5 RNA, although it is also inherently capable of cleaving
this substrate endonucleolytically.
The minimal H2a pre-mRNA substrate that we routinely use
to analyze 3-end processing in vitro contains 38 nucleotides
upstream of the cleavage site, including the stem-loop (Fig.
1A). To determine the minimal length upstream of the cleav-
age site that allows endonucleolytic cleavage, we constructed
DCP10 (Fig. 7A) and DCP15 (not shown) RNA substrates.
In these substrates, the cleavage site was preceded by 10 or 15
nucleotides found in the same position in the H2a pre-mRNA
(Fig. 1A). Incubation of the DCP10 substrate in a mouse
nuclear extract yielded a U7-dependent product that migrated
significantly slower than mononucleotides (Fig. 7C, lane 3).
Generation of the product was blocked by the anti-M oligonu-
cleotide and thus was dependent on the U7 snRNP (Fig. 7C,
lane 4). Electrophoresis in a high-resolution gel next to appro-
priate size markers revealed that DCP10 was cleaved endo-
nucleolytically at the expected site, generating a 10-nucleotide
product (see Fig. S3, lane 5, in the supplemental material). The
DCP15 RNA was also cleaved endonucleolytically, generat-
ing a 15-nucleotide-long product (see Fig. S3, lane 3, in the
supplemental material). Thus, cleavage is endonucleolytic if
the 5 end of the transcript extends 21 nucleotides from the
start of the HDE and exonucleolytic if the 5 end of the tran-
script extends between 9 and 16 nucleotides from the start of
the HDE.
Xrn2 knockdown stabilizes downstream products in GAPDH
(glyceraldehyde-3-phosphate dehydrogenase) but not histone
pre-mRNAs in vivo. According to the “torpedo model,” degra-
dation of the DCP in the nascent transcript promotes release
of RNA polymerase II from the DNA template, resulting in
termination of transcription (3, 21, 29, 37). In support of this
model, the nuclear 5-to-3 exonuclease Xrn2 has been impli-
cated in transcription termination during generation of poly-
adenylated mRNAs in yeast and mammalian cells (16, 18, 22,
39). Our in vitro results suggest that CPSF-73 rather than Xrn2
could be the 5 exonuclease that degrades the DCP in histone
FIG. 7. Switching between the 5 exonuclease and endonuclease
modes. (A) Sequence of DCP derivatives extended at the 5 end by 5
or more nucleotides and labeled at the 5 end (asterisk). The positions
of phosphorothioate (s) and 2-O-methyl (m) modifications are indi-
cated. (B) High-resolution-gel analysis of the U7-dependent products
generated by incubation of the DCP5/scs (lane 1) and DCP5/m5
(lanes 2 and 5) substrates in a mouse nuclear extract (NE). Lanes 3 and
4 contain products of complete digestion of the DCP5/m5 RNA with
the yeast Xrn1 5 exonuclease and the S1 nuclease, respectively. Lane
6 contains a mixture of two synthetic oligonucleotides labeled at the 5
end, mACC and mACCC, which serve as size markers. The 5-nucle-
otide product that results from cleavage at the natural endonucleo-
lytic site is indicated with an arrow. (C) U7-dependent cleavage of
the DCP10 substrate under control conditions or in the presence
of the anti-U7 oligonucleotides, as indicated. Degradation of the
DCP2/s (lane 1) substrate is shown to indicate the positions of
mononucleotides.
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pre-mRNAs in vivo, potentially promoting termination of tran-
scription on histone genes. To test this hypothesis, we analyzed
the effect of knockdown of Xrn2 on accumulation of the DCPs
from both the polyadenylated GAPDH transcript and the
Hist2H2AA transcript. Each of these genes is quite close to
another gene, and hence, transcription termination occurs
within 	1,000 nucleotides of the 3 cleavage site (Fig. 8A). The
transcription termination site of the mouse orthologue of the
Hist2H2AA gene has been mapped to about 600 nucleotides
after the cleavage site (5).
We used two different siRNAs to downregulate Xrn2 in
HeLa cells. Each of the two siRNAs significantly reduced Xrn2
levels, although their combination was the most effective (Fig.
8B, lanes 2 to 4). To determine what effect Xrn2 knockdown
had on stabilization of downstream products of GAPDH and
Hist2H2AA pre-mRNAs, qRT-PCR was performed. We de-
signed oligonucleotide primers that target a region of the
GAPDH pre-mRNA 233 to 295 nucleotides downstream from
the cleavage site as well as primer sets which target regions 140
to 197 and 457 to 526 nucleotides downstream of the
Hist2H2AA cleavage site (Fig. 8A). To determine the amounts
of the DCP relative to those of the mature mRNA, we also
FIG. 8. Xrn2 is not required for degradation of Hist2H2AA DCP in vivo. (A) Probe design for qRT-PCR. Primers were designed to probe
regions within the mature mRNAs (3 End) of both GAPDH and Hist2HAA for normalization purposes. Additional oligonucleotide sets were
designed to target regions 140 to 197 nucleotides (nt) and 457 to 526 nucleotides downstream of the Hist2H2AA cleavage site (H2A #1
Downstream and H2A #2 Downstream, respectively) as well as a region 233 to 295 nucleotides downstream of the GAPDH cleavage site (GAPDH
downstream). IFFO, intermediate filament family orphan. (B) siRNA-mediated downregulation of Xrn2 in HeLa cells. Individual Xrn2-1 and
Xrn2-2 siRNAs (lanes 3 and 4) as well as their combination (lane 2) were used to reduce levels of Xrn2. HeLa cells were collected 72 h after second
siRNA transfection and subjected to Western blot analysis using an anti-Xrn2 antibody. A cross-reacting band detected with the Xrn2 antibody
serves as the loading control. (C) HeLa cells were treated as in panel B, and RNA was prepared by Trizol extraction. RT reactions were performed
using Moloney murine leukemia virus reverse transcriptase and resultant cDNAs subjected to quantitative PCR using the primers described for
panel A. Columns represent average stabilization values from three independent experiments, and error bars represent 1 standard deviation.
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used oligonucleotide primers which amplify target sequences
upstream of the 3 cleavage site in each transcript (3-end
regions). Relative amounts of downstream products were de-
termined by comparing the CT values of downstream PCRs
with those of the 3-end reactions for each knockdown and
normalizing these to the values from control siRNA-treated
cells. Typically, we observed a difference in CT values of about
eight cycles between the downstream fragment and the 3
fragment from the mRNA in control cells, implying that the
concentration of the downstream fragment was between 0.1
and 1% relative to the mature mRNA. The absolute CT value
for the fragment within both the GADPH and the histone
mRNAs (3 end) varied by less than one cycle among the
different samples, indicating that there was not a significant
change in either mature mRNA as a result of the siRNA
treatments. This analysis allowed us to determine CT values
which were used to calculate relative differences in the
amounts of downstream products between the knockdown
cells and the control cells. Xrn2 knockdown had little effect
(
2-fold difference) on the amounts of Hist2H2AA down-
stream products (Fig. 8C). The distal downstream product
displayed a marginal stabilization in all three knockdowns
while the proximal downstream product showed a slight desta-
bilization. In contrast, there was a substantial increase in the
amount of downstream product from the GAPDH transcript
(indicative of its stabilization) in all three knockdowns of Xrn2.
Knockdown of Xrn2 with either individual siRNA resulted in a
stabilization of between 5- and 10-fold, while the combination
knockdown revealed a 15-fold stabilization on average (Fig.
8C), consistent with the degree of knockdown of Xrn2 ob-
served by Western blotting. Taken together, these data indi-
cate that the Xrn2 is involved in the degradation of the
GAPDH downstream product but not the Hist2H2AA down-
stream products. This is consistent with the possibility that
after cleavage of the histone pre-mRNA, the 5 exonuclease
activity of CPSF-73 (and not Xrn2) is involved in degradation
of the downstream product. Note that knockdown of any com-
ponent of the 3-end-processing machinery would result in the
increase of the downstream fragment due to a failure to pro-
cess the pre-mRNA, and hence, direct analysis of the effect of
knocking down CPSF-73 is not possible.
DISCUSSION
The U7-dependent nuclease degrades the DCP in the 5-
to-3 direction and stalls at modified nucleotides. Histone pre-
mRNAs are cleaved at the 3 end by a multicomponent pro-
cessing machinery that includes the U7 snRNP bound to a
region downstream of the cleavage site (10). Following cleav-
age in vitro, the DCP is rapidly degraded to mononucleotides
by a nuclease that also depends on the U7 snRNP. To dem-
onstrate that degradation is carried out by a 5-to-3 exoribo-
nuclease, we incorporated differently modified nucleotides into
specific sites in the DCP RNA: 2-O-methyl nucleotides, de-
oxynucleotides, and phosphorothioate nucleotides. Each mod-
ification resulted in the accumulation of intermediate products
whose sizes clearly demonstrated that degradation begins from
the 5 end and stalls at the modified nucleotide; thus, it be-
haves as a typical 5 exonuclease. The strongest block was
created by a 2-O-methyl modification, which nearly com-
pletely stopped progression of the exonuclease. A single de-
oxynucleotide located in the same position was relatively well
tolerated by the U7-dependent exonuclease, whereas the phos-
phorothioate modification had an intermediate ability to block
the degradation of the DCP.
The U7-dependent 5 exonuclease activity is processive and
proceeds past the HDE, suggesting that it can readily displace
the U7 snRNP from the substrate. Thus, binding of the U7
snRNP to the HDE is required only to recruit the 5 exonu-
clease and initiate degradation. It is not known whether the
exonuclease acts by itself to displace the U7 snRNP or requires
assistance from other proteins present in the nuclear extract.
However, given that the reaction occurs in the presence of
EDTA, the involvement of a conventional helicase in unwind-
ing the RNA duplex formed between the U7 snRNA and the
HDE seems unlikely.
Two observations argue against the possibility that in vitro
degradation of the DCP in histone pre-mRNA is carried out by
the two known and closely related 5 exonucleases, Xrn1 and
Xrn2. First, both enzymes depend on divalent ions and are
completely inactivated by low concentrations of EDTA (32,
35). Second, the 5 exonuclease activity of Xrn1 or Xrn2 re-
quires the presence of a 5 phosphate (32–35). UV cross-
linking studies strongly suggest that the DCP in histone
pre-mRNA is degraded by CPSF-73, which was the only U7-
dependent protein detected in the vicinity of the first scissile
bond during degradation of both the DCP and the DCP2/s
RNAs. Moreover, the U7-dependent activity degrading the
DCP in histone pre-mRNA shares a number of similarities
with the activity of RNase J1, which, together with CPSF-73,
belongs to the -CASP subfamily of the metallo--lactamase
proteins (4, 9, 23). RNase J1 was initially characterized as an
endonuclease involved in processing of mRNA precursors in
Bacillus subtilis (14) and subsequently shown to also function
as a 5-to-3 exonuclease in mRNA degradation and rRNA
processing (24). Altogether, this analysis strongly supports the
notion that CPSF-73 possesses both endonuclease and 5 exo-
nuclease activities.
In contrast to our results, a bacterially expressed N-terminal
fragment of human CPSF-73 functions only as an endonucle-
ase and fails to degrade RNA substrates in the 5-to-3 direc-
tion (23). One explanation is that the 5 exonuclease activity of
CPSF-73 requires the assistance of a second component of the
processing complex and can be observed only in nuclear ex-
tracts or reconstituted systems. It is also possible that the 5
exonuclease (but not the endonuclease) activity of CPSF-73
vitally depends on the C-terminal portion of the protein. This
interpretation is supported by recent crystallographic studies,
which demonstrated the importance of the C-terminal domain
for the activity of RNase J1 (8).
Previously, an activity that degrades the DCP during histone
pre-mRNA processing has been identified in mammalian nu-
clear extracts by Walther et al. (38). In contrast to our results,
this activity stalled at guanine nucleotides and hence generated
a family of fragments trimmed at the 5 end rather than mono-
nucleotides. Further studies are required to determine its re-
lation to CPSF-73, although the dependence on the U7 snRNP
and resistance to EDTA suggest that the two activities repre-
sent the same enzyme.
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The distance of the 5 end of the substrate from the HDE
determines whether CPSF-73 acts as an endonuclease or a 5
exonuclease. Truncated DCP substrates containing 7 or fewer
nucleotides upstream of the HDE are not degraded by CPSF-
73, yet they bind the U7 snRNP with normal efficiency. Ex-
tending the sequence 5 of the HDE to 9 nucleotides resulted
in a substrate that is degraded, but at a lower efficiency than
the normal DCP substrate containing 11 nucleotides in this
region. The sequence upstream of the HDE can be changed
without a major adverse effect on the degradation efficiency,
demonstrating that the sufficient space rather than a specific
sequence is critically important. These results are consistent
with the fact that in natural histone pre-mRNAs, the region
between the HDE and the cleavage site consists of at least 9
nucleotides and is not conserved at the sequence level (2). Our
preliminary cross-linking experiments revealed that the region
upstream of the HDE interacts in a U7-dependent manner
with a group of proteins (unpublished results), which are likely
involved in recruiting and/or activating CPSF-73.
Surprisingly, a DCP derivative extending 16 nucleotides 5 of
the start of the HDE (DCP5 RNA) and thus containing the
normal endonucleolytic cleavage site was also degraded from
the 5 end. Endonucleolytic cleavage of this substrate was
activated by blocking the 5 end of the DCP5 RNA with a
2-O-methyl group. Thus, CPSF-73 preferentially uses the 5
exonuclease mode on the DCP5 RNA, although it is intrin-
sically capable of cleaving this substrate endonucleolytically.
Interestingly, as many as four major sites located close to the 5
end were cleaved upon blockage of the 5 end of the DCP5
substrate, with the natural cleavage site being used only rarely.
Thus, the processing complex assembled on the DCP5 sub-
strate leaves CPSF-73 flexibility in selecting sites for endonu-
cleolytic cleavage. Importantly, exclusive cleavage at the cor-
rect site was achieved by adding 5 more nucleotides to the 5
end of the DCP5 RNA (DCP10 substrate) instead of
blocking this end by a 2-O-methyl group. Perhaps, the region
upstream of the cleavage site in the DCP10 substrate is
sufficiently long to interact with a component of the processing
machinery, which may stabilize CPSF-73, directing cleavage to
the correct site. An important role in preventing the 5 exonu-
clease mode in processing of the DCP10 RNA may also be
played by the fact that the 5 end is located too far away from
the HDE and is thus not easily accessible to CPSF-73.
Xrn2 is not required for degradation of the DCP in histone
pre-mRNA in vivo. Recent in vivo and in vitro studies demon-
strated that the degradation of the DCP during cleavage/poly-
adenylation involves the well-characterized 5 exonuclease
Xrn2 (16, 18, 22, 39). We demonstrated that downregulation of
Xrn2 by RNAi does not result in significant stabilization of the
DCP generated from the Hist2H2AA transcript, while, as ex-
pected, the corresponding product from the transcript encod-
ing GAPDH was stabilized in the same cells, in agreement with
previous studies of polyadenylated mRNAs (15, 39). Thus, it is
likely that the 5 exonuclease activity of CPSF-73 degrades the
DCP in histone pre-mRNA also in vivo while the same func-
tion for all other protein-encoding transcripts is carried out by
Xrn2. The difference may reflect the fact that 3-end process-
ing of conventional pre-mRNAs is directed by the upstream
AAUAAA signal, which recruits CPSF subunits, including
CPSF-73 (26), whereas in 3-end processing of histone pre-
mRNA, the recruitment of CPSF-73 critically depends on the
downstream HDE, which interacts with the U7 snRNP. Fol-
lowing processing of histone pre-mRNA, CPSF-73 likely re-
mains associated with the U7 snRNP and is perfectly posi-
tioned to use its preferential 5 exonuclease activity to degrade
the DCP. It is possible that Xrn2 plays a supportive role, for
example, by continuing degradation of the DCP after dissoci-
ation of CPSF-73 from the substrate. This interpretation is
consistent with our in vivo results demonstrating that the most
distal region of the histone transcript is moderately stabilized
by siRNA-mediated depletion of Xrn2 while the upstream
fragment is not.
One obvious function for the 5 exonuclease activity of
CPSF-73 in vivo may be to degrade the region immediately
downstream of the cleavage site and therefore to liberate the
U7 snRNP from its base pairing association with the HDE for
another round of 3-end processing, as previously suggested
(38). In addition, an attractive possibility is that CPSF-73 con-
tinues degradation into more-downstream regions of the nas-
cent histone pre-mRNA, ultimately resulting in displacement
of RNA polymerase II from the DNA template and termina-
tion of transcription, as postulated for Xrn2 in the torpedo
mechanism (3, 21, 29, 37). Indeed, mutations within the 3-
end-processing elements in histone pre-mRNAs (the stem-
loop and the HDE) prevent transcription termination in vivo
(5), suggesting that as in cleavage/polyadenylation (3), 3-end
processing of histone pre-mRNA is functionally linked to the
release of RNA polymerase II from histone genes.
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exonuclease activity involved in forming the 3 products of histone pre-
mRNA processing in vitro. RNA 4:1034–1046.
39. West, S., N. Gromak, and N. J. Proudfoot. 2004. Human 533 exonuclease
Xrn2 promotes transcription termination at co-transcriptional cleavage sites.
Nature 432:522–525.
40. Zhao, J., L. Hyman, and C. Moore. 1999. Formation of mRNA 3 ends in
eukaryotes: mechanism, regulation, and interrelationships with other steps in
mRNA synthesis. Microbiol. Mol. Biol. Rev. 63:405–445.
42 YANG ET AL. MOL. CELL. BIOL.
